DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationMRCS

Chronic kidney disease: diagnosis and staging

Essential points for quick revision.

Synopsis

Confirm chronic kidney disease correctly, stage both filtration and albuminuria, identify its cause, and recognise patients needing urgent or specialist assessment.

  • CKD requires a kidney structural or functional abnormality present for more than 3 months; one low eGFR during acute illness is acute kidney injury until chronicity is demonstrated.
  • Classify eGFR as G1 at least 90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29 and G5 below 15 mL/min/1.73 m², but G1 or G2 alone is not CKD without another marker of damage.
  • Pair the G category with urine albumin:creatinine ratio: A1 below 3, A2 3–30 and A3 above 30 mg/mmol; the combination predicts renal and cardiovascular risk better than either value alone.

Key red flags

Pulmonary oedema, dangerous hyperkalaemia, severe metabolic acidosis, uraemic encephalopathy or pericarditis requires immediate hospital and renal assessment, not outpatient confirmation of chronicity.

Investigation priorities

01
Serial creatinine and eGFRFirst step

Confirm chronicity, establish the G category and detect acute or sustained progression.

Management branches

CONFIRMNew low eGFR

An adult has a first creatinine-based eGFR below 60 mL/min/1.73 m².

  1. Check prior results, current illness, hydration, urine output, medicines and obstruction symptoms, and assess immediately for AKI or a renal emergency.
  2. Repeat renal function within the NICE-recommended acute exclusion interval when deterioration is new, adjusting urgency to the clinical picture.
REFERNephrology discussion or referral

Risk, progression, albuminuria, haematuria, hypertension or suspected cause exceeds routine primary-care management.

Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom